Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials.

Autor: Maurer M; Urticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité-Universitätsmedizin Berlin, Germany; Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany. Electronic address: marcus.maurer@charite.de., Ensina LF; Federal University of São Paulo, São Paulo, Brazil; CPAlpha Clinical Research Center, Barueri, Brazil., Gimenez-Arnau AM; Department of Dermatology, Hospital del Mar-IMIM, Universitat Pompeu Fabra, Barcelona, Spain., Sussman G; Division of Allergy and Clinical Immunology, University of Toronto, Canada., Hide M; Department of Dermatology, Hiroshima University, Hiroshima, Japan; Department of Dermatology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan., Saini S; Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, MD, USA., Grattan C; St John's Institute of Dermatology, Guy's and St Thomas' Hospitals NHS Foundation Trust, London, UK., Fomina D; Center of Allergy and Immunology, Clinical State Hospital 52, Moscow Ministry of Healthcare, Moscow, Russia; Department of Clinical Allergology and Immunology, I M Sechenov First Moscow State Medical University, Moscow, Russia., Rigopoulos D; A Sygros University Hospital of Venereal and Skin Diseases, Athens, Greece., Berard F; Département d'Allergologie et Immunologie Clinique, CHU Lyon-Sud, Pierre Bénite Cedex, France., Canonica GW; Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy; Department of Biomedical Science, Humanitas University-Pieve Emanuele, Milan, Italy., Rockmann H; Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Irani C; Internal Medicine and Clinical Immunology, Saint Joseph University, Beirut, Lebanon., Szepietowski JC; Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland., Leflein J; Allergy and Immunology Associates of Ann Arbor, PC Ann Arbor, Michigan, MI, USA., Bernstein JA; University of Cincinnati College of Medicine Division of Rheumatology, Allergy, and Immunology and Bernstein Clinical Research Center, Cincinnati, OH, USA., Peter JG; Division of Allergology and Clinical Immunology, Department of Medicine, University of Cape Town, Cape Town, South Africa; Allergy and Immunology Unit, University of Cape Town Lung Institute, Cape Town, South Africa., Kulthanan K; Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Godse K; Department of Dermatology, D Y Patil School of Medicine, Navi Mumbai, Maharashtra, India., Ardusso L; Department of Pulmonology, Allergy and Immunology, School of Medicine, National University of Rosario, Rosario, Santa Fe, Argentina., Ukhanova O; Scientific Medical Center of General Therapy and Pharmacology, Stavropol, Russia., Staubach P; Department of Dermatology, University Medical Center, Mainz, Germany., Sinclair R; Department of Dermatology, St Vincent's Hospital, The Skin and Cancer Foundation of Victoria and The University of Melbourne, Victoria, VIC, Australia., Gogate S; Colorado Allergy and Asthma Centers, Denver, Colorado, CO, USA., Thomsen SF; Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Biomedical Sciences, Copenhagen, Denmark., Tanus T; Kern Allergy Medical Clinic, Bakersfield, CA, USA., Ye YM; Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, South Korea., Burciu A; Novartis Pharma, Basel, Switzerland., Barve A; Novartis Pharmaceuticals, East Hanover, New Jersey, NJ, USA., Modi D; Novartis Pharmaceuticals, East Hanover, New Jersey, NJ, USA., Scosyrev E; Novartis Pharmaceuticals, East Hanover, New Jersey, NJ, USA., Hua E; China Novartis Institutes for Biomedical Research, Shanghai, China., Letzelter K; Novartis Pharma, Basel, Switzerland., Varanasi V; Novartis Healthcare Private, Hyderabad, India., Patekar M; Novartis Pharma, Basel, Switzerland., Severin T; Novartis Pharma, Basel, Switzerland.

Publikováno v: Lancet (London, England) [Lancet] 2024 Jan 13; Vol. 403 (10422), pp. 147-159. Date of Electronic Publication: 2023 Nov 23.

Evaluation of the adult patient with atopic dermatitis.

Autor: Bruin Weller, M. S.¹, Rockmann, H.¹, Knulst, A. C.¹, Bruijnzeel‐Koomen, C. A. F. M.¹

Publikováno v: Clinical & Experimental Allergy. Mar2013, Vol. 43 Issue 3, p279-291. 13p. 2 Color Photographs, 1 Diagram, 1 Chart.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.